ArticleMolecular neurobiology2025
Genetically Elevated Neutrophil Count Is Associated with Poor Outcome Following Ischemic Stroke: A Mendelian Randomization Study.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Serum Hepatocyte-Derived Fibrinogen-Related Protein-1: A Novel Biomarker for Severity and Clinical Outcome in Acute Ischemic Stroke.Journal of inflammation research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The aim of this study was to investigate the association between genetically proxied white blood cell (WBC) subtype counts and functional outcome following ischemic stroke. Genetic proxies for counts of neutrophils, lymphocytes, monocytes, eosinophils, and basophils were identified from the Blood Cell Consortium genome-wide association study meta-analysis (N = 562,243 European participants). A poor post-stroke functional outcome was defined as a modified Rankin Scale (mRS) score > 2 at 3 months. Summary-level genetic associations with mRS > 2 (mRS 0-2 vs. 3-6) were obtained from the Genetics of Ischemic Stroke Functional Outcome network (N = 6021). Associations of genetically proxied WBC counts with functional outcome after ischemic stroke were estimated using the random-effects inverse variance weighted method. In univariable MR analysis, genetically proxied higher neutrophil count was nominally associated with poor functional outcome following ischemic stroke (OR = 1.33, 95% CI = 1.05-1.70; P = 0.020). This association was consistent in multivariable MR analysis adjusting for genetic associations with all other WBC subtypes (OR = 1.45, 95% CI = 1.06-1.99; P = 0.021). There were no associations between any other WBC subtypes counts and functional outcome following ischemic stroke. Our findings provide genetic evidence that genetically proxied neutrophil count was associated with poor functional outcome following ischemic stroke. Future studies are needed to replicate this finding and to investigate the molecular mechanisms underlying this association.
Indexed as
Identifiers
40694282What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.